Effects of Coenzyme Q10 Supplementation on Glycemic Control Biomarkers: An Umbrella Review of Meta‐Analyses of Randomised Controlled Trials
Endocrinology, Diabetes & Metabolism · 2026-03 · 9 (2)
DOI: 10.1002/edm2.70182 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 20.03.2026. Verfasst von Vali Musazadeh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Public Health, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Ubiquinone, Glycemic Control, Dietary Supplements, Blood Glucose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Several meta‐analyses suggest that Coenzyme Q10 (CoQ10) supplementation is associated with glycemic control; however, findings about fasting blood glucose (FBG) and haemoglobin A1c (HbA1c) remain inconsistent across studies. Accordingly, this study aimed to synthesise the results to present a firm conclusion in relation to the efficacy of CoQ10 on glycemic control.
Methods
A systematic search was conducted to find meta‐analyses of randomised controlled trials using PubMed, Scopus, Web of Science and the Cochrane Database of Systematic Reviews from inception to March 6, 2025. Also, the methodological quality of included studies was evaluated using the AMSTAR2 tool.
Results
In total, eight meta‐analyses were included in this umbrella systematic review and meta‐analysis. Pooled analysis using standardized mean difference analysis demonstrated that CoQ10 is associated with decreased FBG. While it didn't exert any significant changes on the HbA1c, HOMA‐IR, and insulin levels. In addition, the combined effect of CoQ10 using weighted mean difference analysis revealed that CoQ10 is able to decrease the FBG (5.04 mg/dL), HbA1c (0.17%), HOMA‐IR (0.72), and insulin (1.32 μIU/mL) levels significantly.
Conclusion
The present study suggests that CoQ10 supplementation may have a moderate beneficial effect on glycemic control in diabetic patients, though findings differ depending on analytic approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Research Committee, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
- Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
- Department of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
- Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran.
- Department of Nutrition, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
- Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Vali Musazadeh, Maryam Falahatzadeh, Mahsa Mahmoudinezhad, Mehrdad Jamali, Pedram Pam, Farzad Shidfar
Zitieren
APA
Musazadeh, V., Falahatzadeh, M., Mahmoudinezhad, M., Shahhooseini, E., Jamali, M., Pam, P., & Shidfar, F. (2026). Effects of Coenzyme Q10 Supplementation on Glycemic Control Biomarkers: An Umbrella Review of Meta‐Analyses of Randomised Controlled Trials. Endocrinology, Diabetes & Metabolism, 9(2). https://doi.org/10.1002/edm2.70182
Vancouver
Musazadeh V, Falahatzadeh M, Mahmoudinezhad M, Shahhooseini E, Jamali M, Pam P, et al. Effects of Coenzyme Q10 Supplementation on Glycemic Control Biomarkers: An Umbrella Review of Meta‐Analyses of Randomised Controlled Trials. Endocrinology, Diabetes & Metabolism. 2026;9(2). doi:10.1002/edm2.70182
BibTeX
@article{Musazadeh2026,
author = {Musazadeh, Vali and Falahatzadeh, Maryam and Mahmoudinezhad, Mahsa and Shahhooseini, Erfan and Jamali, Mehrdad and Pam, Pedram and Shidfar, Farzad},
title = {Effects of Coenzyme Q10 Supplementation on Glycemic Control Biomarkers: An Umbrella Review of Meta‐Analyses of Randomised Controlled Trials},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2026},
volume = {9},
number = {2},
doi = {10.1002/edm2.70182}
}
EUVIMED